NCT05432986

Assessment of CSF Shunt Flow With Thermal Measurements B

Name: Clinical Trial NCT05432986
Creator: Rhaeos, Inc.
Keywords: Hydrocephalus, Thermal Anisotropy Measurement Device, device, clinical trial, United States of America

Assessment of Flow in Cerebrospinal Fluid Shunts With a Wireless Thermal Anisotropy Measurement Device, Phase B

Rhaeos, Inc.·ClinicalTrials.gov·device·Device trialRecruiting

View on ClinicalTrials.gov →

Study focus

Disease/Condition: Hydrocephalus
Drug/Device/Intervention: Thermal Anisotropy Measurement Device
Study type: Observational
Intervention type: device

Sponsor & location

Primary sponsor: Rhaeos, Inc.
Location: Chicago,Chicago,Saint Louis, United States of America

Timeline & enrollment

Phase: N/A
Start date: Jul 07, 2022
End date: Oct 01, 2022
Enrollment: 100 participants

Primary outcome

Diagnostic Performance

Summary

This study evaluates the performance of a non-invasive thermal measurement device for assessing CSF shunt flow. Patients with an existing implanted shunt and symptoms of shunt malfunction will be evaluated with the study device.

ICD-10 classifications

HydrocephalusHydrocephalus, unspecifiedOther hydrocephalusCongenital hydrocephalusObstructive hydrocephalus

Data source

Registry: ClinicalTrials.gov
Trial ID: NCT05432986
Type: Device Trial

About this record

Access comprehensive clinical trial information for NCT05432986 through Pure Global AI's free database. This phase not specified trial is sponsored by Rhaeos, Inc. and is currently Recruiting. The study focuses on Hydrocephalus. Target enrollment is 100 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.